Definity (Perflutren Lipid Microspheres) Patent Expiration, LOE Window & CMS Spending

Definity (Perflutren Lipid Microspheres) by Lantheus Medical Imaging: FDA Orange Book core substance LOE 2035-12-28 (last listed 2037-05-04), 0 AB generics, $7.0M 2024 CMS Part D & Medicaid spend, and 7 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorLantheus Medical Imaging
FDA Application & PathwayN021064 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2035-12-28
Last Listed Patent or Exclusivity Date2037-05-04
Orange Book Patents (*PED Extensions)11 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$7.0M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$7.0M
Reported Wholesale Price Change (CA SB 17)7 WAC filings (max 23.6% 2-yr change)